News Sentiment

RCEL sentiment intelligence

Avita Medical Ltd news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 63 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 4.06 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

78/100 classification confidence.

Company focus 63

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

-19.8% over one week, +3.8% over four weeks, trend active, and below fair value.

Latest direct headline Positive

AVITA Medical to announce Q2 2026 financial results on August 6

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 78/100 classification
One-week reaction -19.8% Price reacting lower
Trend fit Trend active 3.8% over four weeks
Fair value -54.6% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 14
Neutral 42
Negative 7

Relevance

Why the article matched

Direct first
Direct company coverage 63
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 16
Stock Titan 6
TradingView 5
TradingKey 5
simplywall.st 4
Moomoo 3
Investing.com 3
Yahoo! Finance Canada 2

Event Lens

What the news is about

Classified themes
Market update 32
Earnings 25
Analyst action 3
Capital return 1
Deals and strategy 1
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 63
scanx.trade Direct company coverage

AVITA Medical to announce Q2 2026 financial results on August 6

AVITA Medical has announced that it will release its second-quarter 2026 financial results after the U.S. financial markets close on August 6, 2026. The company will also host a conference call and webcast on the same day to discuss its financial performance and recent business h

Tone
Positive 71/100
Event
Earnings
Published
14 Jul 2026 23:42
Source
scanx.trade
Stock Titan Direct company coverage

AVITA Medical Schedules Q2 Results Call for Aug. 6 Webcast

AVITA Medical (NASDAQ: RCEL, ASX: AVH) announced it will release its second quarter 2026 financial results after the close of U.S. financial markets on Thursday, August 6, 2026. The company will host a conference call and webcast at 1:30 p.m. Pacific Time the same day to discuss

Tone
Positive 60/100
Event
Earnings
Published
14 Jul 2026 19:41
Source
Stock Titan
Yahoo! Finance Canada Direct company coverage

AVITA Medical to Announce Second Quarter 2026 Financial Results

AVITA Medical, a therapeutic acute wound care company, announced it will release its second quarter 2026 financial results after the U.S. financial markets close on Thursday, August 6, 2026. The company will host a conference call and webcast on the same day at 1:30 p.m. Pacific

Tone
Neutral 50/100
Event
Earnings
Published
14 Jul 2026 19:41
Source
Yahoo! Finance Canada
Simply Wall Street Direct company coverage

RCEL: Renewed Adoption Confidence Will Support Future Bullish Repricing

Analysts have raised their consolidated price target for AVITA Medical (RCEL) to $12, citing renewed confidence in RECELL adoption, organic revenue momentum, and sufficient working capital. While bullish, some analysts acknowledge potential risks if RECELL uptake slows or executi

Tone
Positive 74/100
Event
Earnings
Published
13 Jul 2026 17:41
Source
Simply Wall Street
TradingView Direct company coverage

Enterprise value to EBITDA forward of AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs – MUN:51KB

This article provides the enterprise value to EBITDA forward for AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs, traded on the Munich Stock Exchange under the symbol MUN:51KB. The information is presented within a financial overview provided by TradingView, detaili

Tone
Neutral 50/100
Event
Market update
Published
12 Jul 2026 17:09
Source
TradingView
Moomoo Direct company coverage

Avita Medical(RCEL) Stock Options Chain | Quotes & News

This article provides details on Avita Medical's (RCEL) stock options chain, offering quotes and news related to the company's financial instruments. It serves as a resource for investors interested in RCEL's options performance and market activities.

Tone
Neutral 50/100
Event
Market update
Published
04 Jul 2026 07:09
Source
Moomoo
Yahoo! Finance Canada Direct company coverage

Avita Medical (RCEL) Upgraded to Buy: Here's Why

Avita Medical (RCEL) has been upgraded to a Zacks Rank #2 (Buy) due to an upward trend in its earnings estimates. The Zacks rating system highlights the strong correlation between revisions in earnings estimates and near-term stock price movements, making this upgrade a positive

Tone
Positive 77/100
Event
Analyst action
Published
03 Jul 2026 16:09
Source
Yahoo! Finance Canada
Moomoo Direct company coverage

Avita Medical Downgraded to Hold From Speculative Buy by Morgans

Morgans has downgraded Avita Medical (ASX:AVH) from a "Speculative Buy" to a "Hold" rating. This change reflects a revised outlook from the analyst following a recent assessment of the company. Investors should consider this updated rating in their evaluation of Avita Medical's s

Tone
Negative 29/100
Event
Analyst action
Published
03 Jul 2026 06:09
Source
Moomoo
TradingView Direct company coverage

Price to sales forward of AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs – ASX:AVH

This page from TradingView displays the "Price to sales forward" financial metric for AVITA Medical Inc Shs Chess Depository Interests, traded on the Australian Securities Exchange under the ticker ASX:AVH. The article provides a high-level overview of the company's financial dat

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 02:39
Source
TradingView
www.marketscreener.com Direct company coverage

AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 3000 Index

AVITA Medical, Inc. (NasdaqCM: RCEL) has been removed from the Russell 3000 Index, along with several other Russell indices including the Russell Small Cap Comp Growth Benchmark, Russell 2500 Growth Benchmark, and Russell 2000 Dynamic Index. This news was published on June 29, 20

Tone
Negative 30/100
Event
Market update
Published
29 Jun 2026 12:47
Source
www.marketscreener.com
TradingView Direct company coverage

Enterprise value to EBITDA forward of Avita Medical, Inc. – NASDAQ:RCEL

This article focuses on the enterprise value to EBITDA forward for Avita Medical, Inc. (NASDAQ: RCEL). It seems to be a financial data point from TradingView, indicating a specific valuation metric for the company. The content primarily presents navigation and various data source

Tone
Neutral 50/100
Event
Market update
Published
28 Jun 2026 18:40
Source
TradingView
The National Law Review Direct company coverage

Bronstein, Gewirtz & Grossman, LLC Is Investigating AVITA Medical

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of AVITA Medical, Inc. (NASDAQ:RCEL) after the company's stock fell 25.8% following the announcement of its CEO's immediate departure. Investors who purchased AVITA securities are encoura

Tone
Negative 30/100
Event
Market update
Published
28 Jun 2026 17:09
Source
The National Law Review
TradingView Direct company coverage

Price to book forward of AVITA Medical Inc – LS:A2P733

This article provides financial information for AVITA Medical Inc (LS:A2P733) on TradingView, specifically focusing on its forward price-to-book ratio. The content is brief, indicating that the market was closed at the time of viewing and no trades were recorded for the stock.

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 11:40
Source
TradingView
TradingView Direct company coverage

Price to sales forward of Avita Medical, Inc. – NASDAQ:RCEL

This article provides financial information for Avita Medical, Inc. (NASDAQ: RCEL), specifically focusing on its forward price-to-sales ratio. It presents a simple table with the period, value, change, and percentage change for this metric, noting that the data is sourced from Fa

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 19:39
Source
TradingView
Moomoo Direct company coverage

BTIG Maintains Avita Medical(RCEL.US) With Hold Rating

BTIG has reiterated its Hold rating for Avita Medical (RCEL.US). This update indicates the firm's ongoing stance on the company's stock.

Tone
Neutral 50/100
Event
Analyst action
Published
24 Jun 2026 04:09
Source
Moomoo
Market source Direct company coverage

AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

AVITA Medical presented new clinical data at the British Burn Association Annual Meeting, showcasing the first U.K. use of its RECELL GO system. A case series of 17 burn and reconstructive surgery patients at Stoke Mandeville Hospital demonstrated successful outcomes and improved

Tone
Positive 74/100
Event
Market update
Published
22 Jun 2026 04:09
Source
Market source
Stock Titan Direct company coverage

AVITA Medical’s burn treatment used in 17 U.K. patients

AVITA Medical (NASDAQ: RCEL) announced the successful use of its RECELL GO system in 17 burn and reconstructive patients in the UK, with all patients discharged without complications and noted workflow benefits for the surgical teams. The findings were presented at the 2026 Briti

Tone
Positive 71/100
Event
Market update
Published
19 Jun 2026 00:09
Source
Stock Titan
TradingKey Direct company coverage

AVITA Medical Inc (RCEL) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides historical dividend and stock split information for AVITA Medical Inc (RCEL). It indicates that AVITA Medical Inc has not distributed any dividends over the past five years and shows no data for stock splits. The page primarily serves as a financial data por

Tone
Neutral 50/100
Event
Capital return
Published
17 Jun 2026 11:09
Source
TradingKey
TradingKey Direct company coverage

AVITA Medical Inc (RCEL) Financial Health: Profitability & Balance Sheet Analysis

AVITA Medical Inc (RCEL) has a current financial score of 7.84, placing it 77th out of 388 in the Biotechnology & Medical Research industry, indicating weak financial status but high operating efficiency. The company reported a quarterly revenue of $19.25M, a 3.98% year-over-year

Tone
Positive 59/100
Event
Earnings
Published
17 Jun 2026 10:09
Source
TradingKey
TradingKey Direct company coverage

AVITA Medical Inc (RCEL) Earnings Forecast: Future EPS & Revenue Growth Estimates

AVITA Medical Inc (RCEL) has an earnings forecast score of 8.00, ranking 163rd in its industry. Analysts have set an average price target of $5.50, with a consensus "Buy" rating based on 5 analysts. The company's recent EPS was -$0.38 against an expectation of -$0.35, and the nex

Tone
Positive 71/100
Event
Earnings
Published
17 Jun 2026 04:41
Source
TradingKey
TradingKey Direct company coverage

AVITA Medical Inc (RCEL) Risk Assessment: Volatility, Financial Risk & Investment Risk

AVITA Medical Inc (RCEL) has a risk assessment score of 2.77, ranking it 191 out of 388 in the Biotechnology & Medical Research industry. The company's beta value of 1.88 indicates higher volatility relative to the S&P 500. The risk assessment also details various financial metri

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 04:41
Source
TradingKey
Stock Titan Direct company coverage

AVITA Medical (RCEL) CFO receives 2,000-share equity grant in Form 4

AVITA Medical's CFO, David D. O'Toole, was granted 2,000 shares of common stock at a reference value of $3.97 per share. This compensation-related award increased his directly held stake to 152,927 shares, which includes unvested Restricted Stock Units (RSUs). The transaction was

Tone
Neutral 50/100
Event
Deals and strategy
Published
12 Jun 2026 20:29
Source
Stock Titan
Stock Titan Direct company coverage

AVITA Medical (RCEL) director adds 5,200 shares in open-market buy

AVITA Medical, Inc. director Woody Joseph Fralin purchased 5,200 shares of the company's common stock at $4.00 per share on June 9, 2026, increasing his direct holdings to 107,961 shares, which include unvested Restricted Stock Units (RSUs). This open-market transaction signals i

Tone
Positive 72/100
Event
Market update
Published
11 Jun 2026 02:11
Source
Stock Titan